113 studies (1 from unattributed sources) on Mots-c curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Independent certificate-of-analysis evidence from third-party labs — the data behind the studies. Updated as new COAs are verified. Read the full grey-market analysis →
| Manufacturer | Batches | Avg purity | |
|---|---|---|---|
| Unknown vendor (review) | 48 | 99.43% | View COA → |
| Peptaris | 41 | 99.51% | View COA → |
| Simple Peptide | 23 | 99.43% | View COA → |
| Planet Peptide | 22 | 99.44% | View COA → |
| Alpha & Omega | 22 | 99.43% | View COA → |
| Verified Peptides | 20 | 99.56% | View COA → |
| Peptira LLC | 14 | 99.57% | View COA → |
| Elite Research | 13 | 99.48% | View COA → |
Recent certificates: #27998 (99.88%) · #38467 (99.9%) · #39354 (99.55%) · #49830 (99.61%) · #54509 (99.37%) · #56471 (99.87%)
Manufacturers with published third-party certificates of analysis for Mots-c. Open a vendor to see every batch we've verified.
This review highlights a significant untapped area of research with profound implications for understanding and treating lung diseases. Given the established roles of MDPs in other complex diseases, their investigatio…
This study provides compelling evidence that exogenous MOTS-c can effectively mitigate myocardial ischemia-reperfusion injury by preserving cardiac function, reducing infarct size, and combating oxidative stress. Give…
This research provides compelling evidence that MOTS-c could serve as a novel and effective therapeutic agent for preventing or treating cardiac dysfunction associated with high-altitude exposure. By actively promotin…
This research highlights MOTS-c as a potential biomarker and therapeutic target for Polycystic Ovary Syndrome (PCOS). The strong association between reduced MOTS-c and mitochondrial dysfunction suggests that restoring…
This research highlights MOTS-c as a promising novel therapeutic candidate for Autism Spectrum Disorder, potentially addressing both behavioral symptoms and underlying neurobiological deficits. The ability of MOTS-c t…
This research provides compelling evidence that MOTS-c and humanin could represent novel therapeutic agents for preventing or treating muscle atrophy, particularly in contexts involving corticosteroid use or other cat…
This research highlights MOTS-c as a promising therapeutic candidate for preventing or treating acute liver injury caused by acetaminophen overdose. Its ability to modulate the MAPK signaling pathway and reduce both n…
This research is highly significant as it identifies MOTS-c as a promising therapeutic candidate for preventing or treating bronchopulmonary dysplasia, a major cause of morbidity in premature infants. By activating th…
This detailed chemical profile is crucial for the unambiguous identification and characterization of MOTS-c in research and development. Accurate chemical identification is the bedrock for all subsequent experimental …
This comprehensive screening program holds immense potential to revolutionize early intervention strategies for newborn hearing loss. By identifying genetic causes early, clinicians can offer more personalized prognos…
This research powerfully highlights the graviola oil extract's potential as a natural, multi-faceted supplement for significantly enhancing livestock productivity and overall health. By effectively improving fattening…
This research highlights a novel role for MOTS-c in modulating adrenal gland metabolism, specifically by enhancing mitochondrial function and energy production without directly impacting steroid hormone synthesis. Thi…
Free, no account — handy when you're working with Mots-c.